|
Post by peppy on Apr 5, 2017 21:16:03 GMT -5
What if they did this? What if RLS was well-funded, say 2 billion dollars? Then RLS announces they are buying out MNKD for a $1 per share price and in addition one share of RLS stock? Then wouldn't the shorts have to cover before the buyout? Couldn't that run the price of MNKD up to say $40-50 per share. Then couldn't shareholders choose to sell, mostly at their investment value and then the shorts would have to pay market price (of possibly $50+ per share) for shares that would only sell to RLS for $1? Wouldn't this allow RLS to then privately continue to privately commercialize Afrezza until the market efforts were more favorable and then offer a new IPO at favorable terms, rather than dilute, unfavorably? This solution would restore $3 billion in lost value and allow prior investors to buy back in when Afrezza is in a position of strength. I mean I'm not saying this will happen, and Matt would have to be a super-handsome financial genius to work out such a scheme, but its possible, right? I think the above would get RLS a nasdaq listing as well. Question mark? It is my dream scenario in the moment.
|
|
|
Post by mnkdfann on Apr 5, 2017 21:22:45 GMT -5
What if they did this? What if RLS was well-funded, say 2 billion dollars? Then RLS announces they are buying out MNKD for a $1 per share price and in addition one share of RLS stock? Then wouldn't the shorts have to cover before the buyout? Couldn't that run the price of MNKD up to say $40-50 per share. Then couldn't shareholders choose to sell, mostly at their investment value and then the shorts would have to pay market price (of possibly $50+ per share) for shares that would only sell to RLS for $1? Wouldn't this allow RLS to then privately continue to privately commercialize Afrezza until the market efforts were more favorable and then offer a new IPO at favorable terms, rather than dilute, unfavorably? This solution would restore $3 billion in lost value and allow prior investors to buy back in when Afrezza is in a position of strength. I mean I'm not saying this will happen, and Matt would have to be a super-handsome financial genius to work out such a scheme, but its possible, right? No, it's really not. Except possibly in the magical land of unicorns and rainbows.
|
|
|
Post by fanz8967 on Apr 5, 2017 21:31:37 GMT -5
What if they did this? What if RLS was well-funded, say 2 billion dollars? Then RLS announces they are buying out MNKD for a $1 per share price and in addition one share of RLS stock? Then wouldn't the shorts have to cover before the buyout? Couldn't that run the price of MNKD up to say $40-50 per share. Then couldn't shareholders choose to sell, mostly at their investment value and then the shorts would have to pay market price (of possibly $50+ per share) for shares that would only sell to RLS for $1? Wouldn't this allow RLS to then privately continue to privately commercialize Afrezza until the market efforts were more favorable and then offer a new IPO at favorable terms, rather than dilute, unfavorably? This solution would restore $3 billion in lost value and allow prior investors to buy back in when Afrezza is in a position of strength. I mean I'm not saying this will happen, and Matt would have to be a super-handsome financial genius to work out such a scheme, but its possible, right? I think the above would get RLS a nasdaq listing as well. Question mark? It is my dream scenario in the moment.
Why would they need to have NASDAQ listing? They would be a privately owned company. They wouldn't even need to trade on OTC BB. They could stay privately owned until they chose to IPO.
|
|
|
Post by peppy on Apr 5, 2017 21:42:37 GMT -5
I think the above would get RLS a nasdaq listing as well. Question mark? It is my dream scenario in the moment.
Why would they need to have NASDAQ listing? They would be a privately owned company. They wouldn't even need to trade on OTC BB. They could stay privately owned until they chose to IPO. RLS would not need to become a nasdaq listing. I see getting a nasdaq listing, and getting to write off the debt MNKD has as a benefit for RLS if they were to buy MNKD. It costs a lot of money to get listed on the nasdaq. plus RLS could raise money by being on the nasdaq? In this moment a pipe dream.
|
|
|
Post by dreamboatcruise on Apr 5, 2017 22:24:13 GMT -5
What if they did this? What if RLS was well-funded, say 2 billion dollars? Then RLS announces they are buying out MNKD for a $1 per share price and in addition one share of RLS stock? Then wouldn't the shorts have to cover before the buyout? Couldn't that run the price of MNKD up to say $40-50 per share. Then couldn't shareholders choose to sell, mostly at their investment value and then the shorts would have to pay market price (of possibly $50+ per share) for shares that would only sell to RLS for $1? Wouldn't this allow RLS to then privately continue to privately commercialize Afrezza until the market efforts were more favorable and then offer a new IPO at favorable terms, rather than dilute, unfavorably? This solution would restore $3 billion in lost value and allow prior investors to buy back in when Afrezza is in a position of strength. I mean I'm not saying this will happen, and Matt would have to be a super-handsome financial genius to work out such a scheme, but its possible, right? Highly unlikely that would happen. One, RLS isn't going to buy MNKD. Additionally a short squeeze in that case would be unlikely as well. No need to rush for the door at inflated price if you know what the buyout price is. Look at PNRA today (one I fortunately own)... it is heavily shorted and acquisition announced... the price didn't rise above the offer price. Third, I don't think a private company can offer non-listed shares as part of the buyout of a listed company. Matt would have to be a Jedi with honed mind trick skills to convince RLS to acquire MNKD.
|
|
|
Post by boytroy88 on Apr 6, 2017 0:11:25 GMT -5
What if they did this? What if RLS was well-funded, say 2 billion dollars? Then RLS announces they are buying out MNKD for a $1 per share price and in addition one share of RLS stock? Then wouldn't the shorts have to cover before the buyout? Couldn't that run the price of MNKD up to say $40-50 per share. Then couldn't shareholders choose to sell, mostly at their investment value and then the shorts would have to pay market price (of possibly $50+ per share) for shares that would only sell to RLS for $1? Wouldn't this allow RLS to then privately continue to privately commercialize Afrezza until the market efforts were more favorable and then offer a new IPO at favorable terms, rather than dilute, unfavorably? This solution would restore $3 billion in lost value and allow prior investors to buy back in when Afrezza is in a position of strength. I mean I'm not saying this will happen, and Matt would have to be a super-handsome financial genius to work out such a scheme, but its possible, right? Highly unlikely that would happen. One, RLS isn't going to buy MNKD. Additionally a short squeeze in that case would be unlikely as well. No need to rush for the door at inflated price if you know what the buyout price is. Look at PNRA today (one I fortunately own)... it is heavily shorted and acquisition announced... the price didn't rise above the offer price. Third, I don't think a private company can offer non-listed shares as part of the buyout of a listed company. Matt would have to be a Jedi with honed mind trick skills to convince RLS to acquire MNKD. "This is the company you are looking for...." "You will offer to buy us out..." "You will offer us $1/share and one share of your stock..." "Feel the force!"
|
|
|
Post by jmkopp on Apr 6, 2017 7:34:50 GMT -5
Wow. I have a doctoral degree in a health-related field and I have never researched anything more in my life than the prospects for Afrezza and other future inhalable Technosphere drugs. I am amazed at how badly I missed. While I will recover financially eventually; I will never recover psychologically. I have three degrees and none was any help to me here. Does that help you? It does help a little
|
|
|
Post by jmkopp on Apr 6, 2017 7:36:32 GMT -5
Wow. I have a doctoral degree in a health-related field and I have never researched anything more in my life than the prospects for Afrezza and other future inhalable Technosphere drugs. I am amazed at how badly I missed. While I will recover financially eventually; I will never recover psychologically. I was going to ask what other stocks you like but ummm..................that's ok. ;-) Nice Falcon; well-played
|
|
|
Post by madog365 on Apr 6, 2017 8:15:53 GMT -5
Not sure how this stock is a keeper at this point. Since FDA approval, has management even delivered once? Stay tuned
|
|
|
Post by careful2invest on Apr 6, 2017 8:30:17 GMT -5
Not sure how this stock is a keeper at this point. Since FDA approval, has management even delivered once? Stay tuned Now there's a voice of confidence!! I am beginning to think that they (MNKD) is finally going to make it happen!! Time will tell!
|
|
|
Post by lookingforlogic on Apr 6, 2017 8:30:53 GMT -5
Wow. I have a doctoral degree in a health-related field and I have never researched anything more in my life than the prospects for Afrezza and other future inhalable Technosphere drugs. I am amazed at how badly I missed. While I will recover financially eventually; I will never recover psychologically. You should not feel bad since your degrees have nothing to do with what happened to you. I have only one degree and just masters and invested pretty late 100,000 and now I have only 20,000. However I went through the same experiance with Sirius radio first just watching it going down from over 60 to 0.05 and then up to 5.0. I started buying when it was 0.50 and sold at 4.00. This time I was cocky and I concluded 0.80 is the bottom. I have never sold even 1 share and I will never do. Are we going to go bankrupt? I think it is 50/50 chance. But that is not so bad if you compare with rullete or lottery. Google the documentary Stock Shock and read some reviews of this movie, it will make you feel better. Of course Mel Karmazin became CEO in 2004 when SIRI was over 9.0 and ran it down to 0.05 in 11.02.2009 announcing bankruptcy filing by 02.17.2009 and two days later John Malone Karmazin's wihte knight bought 40% of shares for $530,000. Do we need white knight and are we having a chance to get one this is a million dollars question.
|
|
|
Post by casualinvestor on Apr 6, 2017 9:30:12 GMT -5
Are we going to go bankrupt? I think it is 50/50 chance. But that is not so bad if you compare with rullete or lottery. Coming to the MNKD game late, this is one of the main things I consider when buying this stock. %chance of folding and getting nothing (100% loss) vs Afrezza takes off (1,000% return). There also the chance that the stocks limps along and has "moderate" gains/losses for a long time It is a gamble at this point, but a 50/50 chance for 10x payout are some great odds. Even a 30% chance for a 10x payout is. None of this is any comfort to anyone who bought MNKD several years ago (sorry), but it's something people buying right now should consider.
|
|
|
Post by slugworth008 on Apr 6, 2017 9:49:44 GMT -5
What NY Lefty said "It ain't over till it's over" - I'm way down also but we still have a pulse.Pretty sure there's a DNR order. Hopefully it's tattooed on Matt's chest
|
|
|
Post by kc on Apr 6, 2017 11:23:01 GMT -5
Wow. I have a doctoral degree in a health-related field and I have never researched anything more in my life than the prospects for Afrezza and other future inhalable Technosphere drugs. I am amazed at how badly I missed. While I will recover financially eventually; I will never recover psychologically. Many of us are in the same situation. Great product but no money to get it properly in the hands of needing patients. I wish that the Board would have sold the company. It might be too late for us common shareholders. Biggest loss I have even taken and it kept sucking me in to buy more. The Product is a game changer but the Paradigm is too big of a hurdle to get into the market place without capital to advertise.
|
|
|
Post by esstan2001 on Apr 6, 2017 11:28:23 GMT -5
Wow. I have a doctoral degree in a health-related field and I have never researched anything more in my life than the prospects for Afrezza and other future inhalable Technosphere drugs. I am amazed at how badly I missed. While I will recover financially eventually; I will never recover psychologically. Many of us are in the same situation. Great product but no money to get it properly in the hands of needing patients. I wish that the Board would have sold the company. It might be too late for us common shareholders. Biggest loss I have even taken and it kept sucking me in to buy more. The Product is a game changer but the Paradigm is too big of a hurdle to get into the market place without capital to advertise. kc- realistically they have 5-6 months operating left (maybe less ?) to get the word out and show the impact to scripts in some targeted areas; I hear the fat lady walking but she may trip up the steps onto the stage (I hope). If she falls, then I think there is a fair chance we get some funding, both dilutive and deal based. I will be at this year's ASM; hope you can make it; although I can't recall if you are back in or still out...
|
|